ChemicalBook > CAS DataBase List > KPT-8602

KPT-8602

Product Name
KPT-8602
CAS No.
1642300-52-4
Chemical Name
KPT-8602
Synonyms
CS-2388;ATG-016;ONO-7706;KPT-8602;Eltanexor;CAS:1642300-52-4;KPT-8602 (KPT 8602;Eltanexor (KPT-8602;Eltanexor, 10 mM in DMSO;Eltanexor (KPT-8602) ,S8397
CBNumber
CB23151727
Molecular Formula
C17H10F6N6O
Formula Weight
428.3
MOL File
1642300-52-4.mol
More
Less

KPT-8602 Property

Boiling point:
574.4±60.0 °C(Predicted)
Density 
1.57±0.1 g/cm3(Predicted)
storage temp. 
Store at -20°C
solubility 
Soluble in DMSO
form 
Solid
pka
13.06±0.50(Predicted)
color 
Off-white to light yellow
More
Less

Hazard and Precautionary Statements (GHS)

More
Less

N-Bromosuccinimide Price

Biorbyt Ltd
Product number
orb611488
Product name
Eltanexor
Packaging
5mg
Price
$430.1
Updated
2021/12/16
Biorbyt Ltd
Product number
orb611488
Product name
Eltanexor
Packaging
50mg
Price
$1149.2
Updated
2021/12/16
DC Chemicals
Product number
DC22589
Product name
Eltanexor
Purity
>98%
Packaging
50mg
Price
$760
Updated
2021/12/16
DC Chemicals
Product number
DC22589
Product name
Eltanexor
Purity
>98%
Packaging
5mg
Price
$208
Updated
2021/12/16
DC Chemicals
Product number
DC22589
Product name
Eltanexor
Purity
>98%
Packaging
10mg
Price
$280
Updated
2021/12/16
More
Less

KPT-8602 Chemical Properties,Usage,Production

Uses

(αE)?-α-?[[3-?[3,?5-?bis(Trifluoromethyl)?phenyl]?-?1H-?1,?2,?4-?triazol-?1-?yl]?methylene]?-?5-pyrimidineacetamide is an exportin-1 inhibitor with anti-leukemic activity. Exportin-1 mediates nuclear trafficking of proteins. (αE)?-α-?[[3-?[3,?5-?bis(Trifluoromethyl)?phenyl]?-?1H-?1,?2,?4-?triazol-?1-?yl]?methylene]?-?5-pyrimidineacetamide can be used to develop treatments for acute lymphoblastic leukemia.

in vivo

KPT-8602 (15 mg/kg; oral gavage; daily for 12 days) shows potent anti-lymphoblastic leukemia activity[1].

Animal Model:Female BALB/c mice (model with the JAK3 (M511I) mutation)[1]
Dosage:15 mg/kg
Administration:Oral gavage; daily for 12 days
Result:Showed a marked reduction in total white blood cell (WBC) counts after 2 days of treatment compared to placebo-treated animals and the WBC counts continued to drop until they reached normal levels (<10,000 cells/μL) by day 12.

KPT-8602 Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

KPT-8602 Suppliers

Musechem
Tel
+1-800-259-7612
Fax
+1-800-259-7612
Email
info@musechem.com
Country
United States
ProdList
4660
Advantage
60
TargetMol Chemicals Inc.
Tel
+1-781-999-5354; +17819995354
Email
marketing@targetmol.com
Country
United States
ProdList
32435
Advantage
58
InvivoChem
Tel
+1-708-310-1919 +1-13798911105
Fax
708-557-7486
Email
sales@invivochem.cn
Country
United States
ProdList
6391
Advantage
58
Cckinase, Inc.
Tel
+1 (732)236-3202
Email
sales@cckinase.com
Country
United States
ProdList
2738
Advantage
58
TargetMol Chemicals Inc.
Tel
+1-781-999-5354;
Email
support@targetmol.com
Country
United States
ProdList
39035
Advantage
58
Aladdin Scientific
Tel
Email
tp@aladdinsci.com
Country
United States
ProdList
57505
Advantage
58

1642300-52-4, KPT-8602Related Search:


  • KPT-8602
  • Eltanexor (KPT-8602
  • CS-2388
  • KPT-8602 (KPT 8602
  • Eltanexor
  • 5-Pyrimidineacetamide, α-[[3-[3,5-bis(trifluoromethyl)phenyl]-1H-1,2,4-triazol-1-yl]methylene]-, (αE)-
  • (E)-3-(3-(3,5-Bis(trifluoromethyl)phenyl)-1H-1,2,4-triazol-1-yl)-2-(pyrimidin-5-yl)acrylamide
  • ATG-016
  • ONO-7706
  • Eltanexor, 10 mM in DMSO
  • Eltanexor (KPT-8602) ,S8397
  • CAS:1642300-52-4
  • 1642300-52-4